ABSCI CORP Notes Payable, Noncurrent
ABSCI CORP (ABSI) had Notes Payable, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermNotesPayable · last filed 2026-03-24
- 2025-12-31: Notes Payable, Noncurrent $0.00.
- 2025-09-30: Notes Payable, Noncurrent $65.00K.
- 2025-06-30: Notes Payable, Noncurrent $161.00K.
- 2025-03-31: Notes Payable, Noncurrent $682.00K.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-24 |
| 2025-09-30 | $65.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $161.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $682.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.26M 10-K · filed 2026-03-24 |
| 2024-09-30 | $2.15M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.12M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.75M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $4.66M 10-K · filed 2025-03-18 |
| 2023-09-30 | $5.55M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.38M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.19M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.98M 10-K · filed 2024-03-21 |
| 2022-09-30 | $6.52M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $7.13M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $531.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.12M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.71M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.35M 10-Q · filed 2021-09-07 |
| 2020-12-31 | $4.14M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |